Managing migraine headaches experienced by patients who self-report with menstrually related migraine: A prospective, placebo-controlled study with oral sumatriptan

Journal of Headache and Pain

Volumn 6, Issue 2, 2005, Pages 81-87

  Dowson, Andrew J ^a   Massiou, Hélèn ^b   Aurora, Sheena K ^c  

^a KING S COLLEGE HOSPITAL   (United Kingdom)

^b HÔPITAL LARIBOISIÈRE   (France)

^c Northwest Neuroscience Institute   (United States)

Author keywords

Headache spectrum; Menstrual migraine; Sumatriptan

Indexed keywords

PLACEBO; SUMATRIPTAN;

ADULT; ARTICLE; CLINICAL PROTOCOL; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CROSSOVER PROCEDURE; DIGESTIVE SYSTEM DISEASE; DOSE RESPONSE; DOUBLE BLIND PROCEDURE; DRUG EFFICACY; DRUG TOLERABILITY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MENSTRUATION; MIGRAINE WITH AURA; MIGRAINE WITHOUT AURA; MULTICENTER STUDY; NEUROLOGIC DISEASE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; PROSPECTIVE STUDY; RANDOMIZED CONTROLLED TRIAL; SELF REPORT; UNITED KINGDOM;

ADMINISTRATION, ORAL; ADULT; CROSS-OVER STUDIES; DOUBLE-BLIND METHOD; FEMALE; GREAT BRITAIN; HUMANS; LUTEAL PHASE; MIDDLE AGED; MIGRAINE DISORDERS; PLACEBOS; PREMENSTRUAL SYNDROME; PROSPECTIVE STUDIES; SELF CARE; SUMATRIPTAN; TREATMENT OUTCOME; VASOCONSTRICTOR AGENTS;

EID: 18744384433     PISSN: 11292369     EISSN: None     Source Type: Journal    
DOI: 10.1007/s10194-005-0156-3     Document Type: Article

References (31)

1. Billie B (1962) Migraine in school children. Acta Paed Scand 51[Suppl 136]:1-151
2. Welch KM, Darnley D, Simkins RT (1984) The role of estrogen in migraine: a review and hypothesis. Cephalalgia 4:227-236
3. Epstein MT, Hockaday JM, Hockaday TDR (1975) Migraine and reproductive hormones throughout the menstrual cycle. Lancet 1:543-546
4. MacGregor EA, Igarashi H, Wilkinson M (1997) Headaches and hormones: subjective versus objective assessment. Headache Quarterly 8:126-136
5. Somerville BW (1972) The role of estradiol withdrawal in the etiology of menstrual migraine. Neurology 22:355-365
6. MacGregor EA (2000) Gynaecological aspects of migraine. Rev Contemp Pharmacother 11:75-90
7. Beckham JC, Krug LM, Penzien DB et al (1992) The relationship of ovarian steroids, headache activity and menstrual distress: A pilot study with female migraineurs. Headache 32:292-297
8. Solbach P, Sargent J, Coyne L (1984) Menstrual migraine headache: results of a controlled, experimental, outcome study of non-drug treatments. Headache 24:75-78
9. Couturier EGM, Bomhof MAM, Knuistingh Neven A et al (2003) Menstrual migraine in a representative Dutch population sample: Prevalence, disability and treatment. Cephalalgia 23:302-308
10. Granella F, Sances G, Allais G et al (2004) Characteristics of menstrual and nonmenstrual attacks in women with menstrually related migraine referred to headache centres. Cephalalgia 24:707-716
11. MacGregor EA, Hackshaw A (2004) Prevalence of migraine on each day of the natural menstrual cycle. Neurology 63:351-353
12. Gross MLP, Barrie M, Bates D et al (1995) The efficacy of sumatriptan in menstrual migraine. Eur J Neurol 2:144-145
13. Stewart WF, Lipton RB, Chee E et al (2000) Menstrual cycle and headache in a population sample of migraineurs. Neurology 55:1517-1523
14. Dowson AJ, Salt R, Clark M, Bundy MJ (2005) Disability associated with headaches occurring inside and outside the menstrual period in migraine sufferers: A general practice study. Headache 45 (in press)
15. Ferrari MD, Roon KI, Lipton RB et al (2001) Oral triptans (serotonin 5-HT1B/1D agonists) in acute migraine treatment: A meta-analysis of 53 trials. Lancet 358:1668-1675
16. Solbach P, Waymer RS (1993) Treatment of menstruation-associated migraine headache with subcutaneous sumatriptan. Obstet Gynecol 82:769-772
17. Facchinetti F, Bonellie G, Kangasniemi P et al, for the Sumatriptan Menstrual Migraine Study Group (1995) The efficacy and safety of subcutaneous sumatriptan in the acute treatment of menstrual migraine. Obstet Gynecol 86:911-916
18. Dalessio DJ, Brown DL, Solbach P et al for the US 311C90 Dose Ranging Study Group (1996) Oral 311C90 is effective in the treatment of menstrual migraine. Cephalalgia 16:400-401
19. Silberstein SD, Massiou H, Le Jeunne C et al (2000) Rizatriptan in the treatment of menstrual migraine. Obstet Gynecol 96:237-242
20. Silberstein SD, Massiou H, McCarroll KA et al (2002) Further evaluation of rizatriptan in menstrual migraine: Retrospective analysis of long-term data. Headache 42:917-923
21. MacGregor EA (1998) Evaluating migraine during menstruation and the potential efficacy of oral eletriptan. Eur J Neurol 5[Suppl 3]:S56-S57
22. Headache Classification Committee of the International Headache Society (1988) Classification and diagnostic criteria for headache disorders, cranial neuralgias and facial pain. Cephalalgia 8[Suppl 7]:19-28
23. Jones B, Kenward MG (1989) The analysis of cross-over trials. Chapman & Hall, London
24. StatXact™ Turbo Network Version 2.11 User Manual (1992) CYTEL Software Corporation, Cambridge, MA 02139
25. MacGregor EA (1996) "Menstrual" migraine: Towards a definition. Cephalalgia 16:11-21
26. Lipton RB, Stewart WF, Cady RK et al (2000) Sumatriptan for the range of headaches in migraine sufferers: Results of the spectrum study. Headache 40:783-791
27. The Oral Sumatriptan International Multiple-Dose Study Group (1991) Evaluation of a multiple-dose regimen of oral sumatriptan for the acute treatment of migraine. Eur Neurol 31:306-313
28. Headache Classification Subcommittee of the International Headache Society (2004) The International Classification of Headache Disorders, 2nd edn. Cephalalgia 24[Suppl 1]:1-160
29. International Headache Society Clinical Trials Subcommittee (2000) Guidelines for controlled trials of drugs in migraine, 2nd edn. Cephalalgia 20:765-786
30. Lipton RB, Goadsby PJ, Sawyer JPC et al (2000) Migraine: Diagnosis and assessment of disability. Rev Contemp Pharmacother 11:63-73
31. Dowson AJ, Ashford EA, Prendergast S et al (1999) Patient-selected dosing in a six-month open-label study evaluating oral sumatriptan in the acute treatment of migraine. Int J Clin Pract Suppl 105:25-33